Henry McCusker
Henry McCusker
Send Message
Henry McCusker
Stop FollowingHenry McCusker
View as an RSS Feed
View Henry McCusker's Articles BY TICKER:
- Aastrom's Renewed Momentum And Appreciation Before Anticipated Offering
- Tengion Restructures
- Geron Exits Stem Cells To Focus On Oncology
- Regenerative Medicine Universe Earnings Report Card Q3/11
- Aastrom Biosciences Q3/11 Earnings Results
- Geron Reports $19.5M Net Loss In Q3, Says R&D Cost To Rise
- Athersys MultiStem PI Data For Acute Myocardial Infarction
- StemCells Q3 2011 Earnings
- Post Excessive Sell-Off, September Is Still In The Wind
- Regenerative Medicine Companies Trading At Huge Discounts
- An Analysis of NeoStem's Q2 Results
- Neuralstem Loses $0.08/Share in Q2
- Athersys Q2 Loss Is Slight Improvement Over Previous Year
- Earnings Report Card, Regenerative Medicine Universe Edition
- BioTime Sees Its Net Loss Widen in Q2
- Cytori Therapeutics Q2/11 Results Are a Net Loss
- BioMimetic Therapeutics: A Breakdown of Second Quarter Results
- Geron Q2 Results: Net Loss of $21.1 Million
- StemCells Reports a Q2 Net Loss of $4M or $0.29 per Share
- NeoStem: Updating the Facts, Economics, Assets and Potential
- Cytori Therapeutics Completes Equity Agreement
- StemCells' 1-for-10 Reverse Stock Split
